DrugPatentWatch Database Preview

Drugs in MeSH Category Central Nervous System Stimulants

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Tris Pharma Inc	DYANAVEL XR	amphetamine	SUSPENSION, EXTENDED RELEASE;ORAL	208147-001	Oct 19, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Novartis	FOCALIN XR	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	021802-004	Aug 1, 2006	AB	RX	Yes	No	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Adare Pharms Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	210279-002	Oct 9, 2018	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Shire Development	VYVANSE	lisdexamfetamine dimesylate	CAPSULE;ORAL	021977-002	Feb 23, 2007		RX	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Shire Development	VYVANSE	lisdexamfetamine dimesylate	CAPSULE;ORAL	021977-003	Feb 23, 2007		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Shire Development	VYVANSE	lisdexamfetamine dimesylate	CAPSULE;ORAL	021977-007	Oct 30, 2014		RX	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Shire Development	VYVANSE	lisdexamfetamine dimesylate	CAPSULE;ORAL	021977-005	Dec 10, 2007		RX	Yes	No	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration